These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 39135)

  • 21. Regulation of receptor binding interactions of 125I-angiotensin II and 125I-[sarcosine1,leucine8]angiotensin II, an angiotensin antagonist, by sodium ion.
    Bennett JP; Snyder SH
    Eur J Pharmacol; 1980 Oct; 67(1):1-10. PubMed ID: 6252018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypercholesterolemia modifies angiotensin II desensitisation and cross talk between alpha(1)-adrenoceptor and angiotensin AT(1) receptor in rabbit aorta.
    Jerez S; Sierra L; Scacchi F; Peral de Bruno M
    Eur J Pharmacol; 2010 Jun; 635(1-3):149-55. PubMed ID: 20303937
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence that the apparent complexity of receptor antagonism by angiotensin II analogues is due to a reversible and syntopic action.
    Liu YJ; Shankley NP; Welsh NJ; Black JW
    Br J Pharmacol; 1992 Jun; 106(2):233-41. PubMed ID: 1393259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcium and angiotensin tachyphylaxis in rat uterine smooth muscle.
    Freer RJ
    Am J Physiol; 1975 May; 228(5):1423-30. PubMed ID: 236670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High affinity binding of 125I-angiotensin II to rat glomerular basement membranes.
    Sraer J; Baud L; Cosyns JP; Verroust P; Nivez MP; Ardaillou R
    J Clin Invest; 1977 Jan; 59(1):69-81. PubMed ID: 187623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Different types of receptor interaction of peptide and nonpeptide angiotensin II antagonists revealed by receptor binding and functional studies.
    Wienen W; Mauz AB; Van Meel JC; Entzeroth M
    Mol Pharmacol; 1992 Jun; 41(6):1081-8. PubMed ID: 1614410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative effects of angiotensin II and angiotensin III in rabbit adrenal and aortic tissues.
    Pendleton RG; Gessner G; Horner E
    J Pharmacol Exp Ther; 1991 Feb; 256(2):614-20. PubMed ID: 1993998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of apoproteins AI and AII in binding of high-density lipoprotein3 to membranes derived from bovine aortic endothelial cells.
    Vadiveloo PK; Fidge NH
    Biochem J; 1992 May; 284 ( Pt 1)(Pt 1):145-51. PubMed ID: 1599393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of receptor cycling in the regulation of angiotensin II surface receptor number and angiotensin II uptake in rat vascular smooth muscle cells.
    Ullian ME; Linas SL
    J Clin Invest; 1989 Sep; 84(3):840-6. PubMed ID: 2760215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of selective, high affinity [125I]-angiotensin and [125I]-bradykinin binding sites in rat intestinal epithelia.
    Cox HM; Munday KA; Poat JA
    Br J Pharmacol; 1986 Jan; 87(1):201-9. PubMed ID: 2869810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiotensin receptors in smooth muscle cells.
    Baudouin M; Devynck MA; Meyer P
    Adv Nephrol Necker Hosp; 1972; 2():181-9. PubMed ID: 4377514
    [No Abstract]   [Full Text] [Related]  

  • 32. Species-related differences in inotropic effects of angiotensin II in mammalian ventricular muscle: receptors, subtypes and phosphoinositide hydrolysis.
    Ishihata A; Endoh M
    Br J Pharmacol; 1995 Jan; 114(2):447-53. PubMed ID: 7881743
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological characterization of the nonpeptide angiotensin II receptor antagonist, U-97018.
    Kushida H; Nomura S; Morita O; Harasawa Y; Suzuki M; Nakano M; Ozawa K; Kunihara M
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1042-53. PubMed ID: 7562467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacology of SC-52458, an orally active, nonpeptide angiotensin AT1 receptor antagonist.
    Olins GM; Corpus VM; Chen ST; McMahon EG; Palomo MA; McGraw DE; Smits GJ; Null CL; Brown MA; Bittner SE
    J Cardiovasc Pharmacol; 1993 Oct; 22(4):617-25. PubMed ID: 7505365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of endothelium in conversion of angiotensin I to angiotensin II in rabbit aorta.
    Saye JA; Singer HA; Peach MJ
    Hypertension; 1984; 6(2 Pt 1):216-21. PubMed ID: 6202632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacology of DuP 532, a selective and noncompetitive AT1 receptor antagonist.
    Wong PC; Hart SD; Chiu AT; Herblin WF; Carini DJ; Smith RD; Wexler RR; Timmermans PB
    J Pharmacol Exp Ther; 1991 Nov; 259(2):861-70. PubMed ID: 1941632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence for the presence and characterization of angiotensin II receptors in rat anterior pituitary membranes.
    Mukherjee A; Kulkarni P; McCann SM; Negro-Vilar A
    Endocrinology; 1982 Feb; 110(2):665-7. PubMed ID: 6276145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro pharmacology of L-158,809, a new highly potent and selective angiotensin II receptor antagonist.
    Chang RS; Siegl PK; Clineschmidt BV; Mantlo NB; Chakravarty PK; Greenlee WJ; Patchett AA; Lotti VJ
    J Pharmacol Exp Ther; 1992 Jul; 262(1):133-8. PubMed ID: 1625192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [3H]DUP 753, a highly potent and specific radioligand for the angiotensin II-1 receptor subtype.
    Chiu AT; McCall DE; Aldrich PE; Timmermans PB
    Biochem Biophys Res Commun; 1990 Nov; 172(3):1195-202. PubMed ID: 2244903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of extracellular calcium concentration on angiotensin AT1 receptor-mediated smooth muscle contraction and antagonism in rabbit aorta.
    Liu YJ
    Eur J Pharmacol; 1992 Nov; 223(2-3):205-9. PubMed ID: 1478269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.